Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
Author: Avi Kapoor | June 28, 2024 07:30am
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
JP Morgan analyst Lisa Gill maintained an Overweight rating and cut the price target from $101 to $86 on May 30. This analyst has an accuracy rate of 60%.
Argus Research analyst Chris Graja maintained a Buy rating and slashed the price target from $100 to $80 on May 8. This analyst has an accuracy rate of 69%.
Recent News: On May 1, CVS Health reported first-quarter sales of $88.4 billion, up 3.7% year over year. It missed the consensus of $89.21 billion.
Cantor Fitzgerald analyst LouiseChenreiterated an Overweight rating with a price target of $215 on June 25. This analyst has an accuracy rate of 69%.
B of A Securities analyst GeoffMeachammaintained a Neutral rating and cut the price target from $180 to $170 on April 17. This analyst has an accuracy rate of 62%.
Recent News: On June 21, Johnson & Johnson announced that it has successfully completed the acquisition of Proteologix, Inc.